Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology
The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression
Frequency of positivity (a) and median values (b) for ER c (circles)... | Download Scientific Diagram
Psychosocial Adjustment to Illness Scale: Factor structure, reliability, and validity assessment in a sample of Greek breast cancer patients: Women & Health: Vol 57, No 6
ΜΙΣΙΤΖΗΣ ΙΩΑΝΝΗΣ | Χειρουργός Μαστού, Διευθυντής, Ιατρικό Ψυχικού
在开放的微流控系统中集成微结构电纺支架，用于<i>体外</i>研究人类患者衍生的原代细胞,ACS Biomaterials Science & Engineering - X-MOL
Study design of the ADEBAR study. | Download Scientific Diagram
Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology
PDF) Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: A multimodality approach for locally advanced breast cancer
PDF) Properties with Potent Antitumor neu HER2/ HLA-A*0201Binding Epitope of Identification of a Novel Immunogenic
Frequency of positivity (a) and median values (b) for ER c (circles)... | Download Scientific Diagram
PDF) The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression
Relative quantification of the CEACAM19 expression via real-time PCR.... | Download Scientific Diagram
Identification of novel breast cancer‐associated transcripts by uniGene database mining and gene expression analysis in normal and malignant cells - Laversin - 2013 - Genes, Chromosomes and Cancer - Wiley Online Library
Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology
Cureus | Matrix-producing Breast Carcinoma: A Rare Subtype of Metaplastic Breast Carcinoma
Percentage (range) of ER-Positive Cells and Mean Fluorescence Channel... | Download Scientific Diagram
Eftychia Lekka - Senior Investigator, Drug Discovery - Biovista | LinkedIn
A) On low power examination, MPC is more cellular peripherally (red... | Download Scientific Diagram
Ioannis Missitzis's research works | Άγιος Σάββας Αντικαρκινικό Νοσοκομείο, Athens and other places
μικροχειρουργική – Διαμαντής Λ. Μισιτζής
![Patients with pathological response have longer TTR [48 months (17–84)]... | Download Scientific Diagram](https://www.researchgate.net/profile/Panteleimon-Kountourakis/publication/43132163/figure/fig2/AS:330189788729344@1455734788034/Patients-with-pathological-response-have-longer-TTR-48-months-17-84-than-patients.png "Patients with pathological response have longer TTR [48 months (17–84)]... | Download Scientific Diagram")
Patients with pathological response have longer TTR [48 months (17–84)]... | Download Scientific Diagram
Διαμαντής Λ. Μισιτζής MD - Página inicial | Facebook
PDF) Macedonia's eastern boundaries | Ioannis Xydopoulos - Academia.edu
PDF) Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties
Ioannis Missitzis's research works | Άγιος Σάββας Αντικαρκινικό Νοσοκομείο, Athens and other places
Georgios PISSAKAS | Alexandra Regional General Hospital, Athens | Department of Radiation Oncology
